Sezary Disease clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma
Sorry, in progress, not accepting new patients
This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as single agent.
Los Angeles, California and other locations
Our lead scientists for Sezary Disease research studies include Herbert Eradat.
Last updated: